XML 21 R43.htm IDEA: XBRL DOCUMENT v3.3.0.814
Stock-Based Compensation (Details) - USD ($)
$ / shares in Units, shares in Thousands
 3 Months Ended 9 Months Ended
Oct. 03, 2015
Sep. 27, 2014
Oct. 03, 2015
Sep. 27, 2014
Stock-Based Compensation Allocation of Recognized Period Expense [Line Items]        
Allocated stock-based compensation expense $ 8,347,000 $ 8,107,000 $ 24,957,000 $ 24,460,000
Stock Options Outstanding Roll Forward [Line Items]        
Options outstanding at beginning of period     3,280  
Options granted     115 32
Options exercised     (342)  
Options canceled     (72)  
Options outstanding at end of period 2,981   2,981  
Weighted-average exercise price of options outstanding at beginning of period     $ 82.85  
Weighted-average exercise price of options granted     121.33 $ 99.22
Weighted-average exercise price of options exercised     74.44  
Weighted average exercise price of options canceled     83.25  
Weighted-average exercise price of options outstanding at end of period $ 85.29   $ 85.29  
Stock Option Fair Value Assumptions and Methodology [Abstract]        
Stock option fair value assumptions, risk free interest rate     1.40% 1.90%
Stock option fair value assumptions, expected life in years     4 years 4 years
Stock option fair value assumptions, expected volatility     29.10% 24.50%
Stock option fair value assumptions, expected dividends     $ 0 $ 0
Weighted-average grant date fair value of options granted     $ 30.85 $ 22.38
Restricted Stock Plan [Member]        
Stock-Based Compensation by Award [Line Items]        
Shares granted     10  
Weighted-average grant date fair value of shares granted     $ 113.88  
Restricted Stock Unit Plan [Member]        
Stock-Based Compensation by Award [Line Items]        
Unvested shares at beginning of period     533  
Shares granted     150  
Shares vested     (144)  
Shares forfeited     (12)  
Unvested shares at end of period 527   527  
Weighted-average grant date fair value of shares unvested at beginning of period     $ 94.38  
Weighted-average grant date fair value of shares granted     119.46  
Weighted-average grant date fair value of shares vested     85.40  
Weighted-average grant date fair value of shares forfeited     99.75  
Weighted-average grant date fair value of shares unvested at end of period $ 103.85   $ 103.85  
Award vesting period     5 years  
Minimum        
Stock Options Outstanding Roll Forward [Line Items]        
Weighted-average exercise price of options outstanding at beginning of period     $ 37.84  
Weighted-average exercise price of options granted     113.88  
Weighted-average exercise price of options exercised     37.84  
Weighted average exercise price of options canceled     79.05  
Weighted-average exercise price of options outstanding at end of period 38.09   38.09  
Maximum        
Stock Options Outstanding Roll Forward [Line Items]        
Weighted-average exercise price of options outstanding at beginning of period     113.36  
Weighted-average exercise price of options granted     134.37  
Weighted-average exercise price of options exercised     98.21  
Weighted average exercise price of options canceled     87.06  
Weighted-average exercise price of options outstanding at end of period $ 134.37   $ 134.37  
Cost of sales [Member]        
Stock-Based Compensation Allocation of Recognized Period Expense [Line Items]        
Allocated stock-based compensation expense $ 668,000 633,000 $ 1,990,000 $ 2,061,000
Selling and administrative expenses [Member]        
Stock-Based Compensation Allocation of Recognized Period Expense [Line Items]        
Allocated stock-based compensation expense 6,626,000 6,355,000 19,686,000 19,345,000
Research and development expenses [Member]        
Stock-Based Compensation Allocation of Recognized Period Expense [Line Items]        
Allocated stock-based compensation expense $ 1,053,000 $ 1,119,000 $ 3,281,000 $ 3,054,000